Flazalone
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Flazalone is an anti-inflammatory drug that has not been approved as a medicine.
Flazalone is an anti-inflammatory drug that has not been approved as a medicine.
Further Analogues
According to Shaomeng Wang and co-workers, replacement of the para-fluoro halogen with a meta,para-dichloro substitution arrangement resulted in dopamine reuptake inhibitors useful in treating cocaine addiction. Whereas Diclazalone achieved a Ki of 10.9nM for the mazindol binding site (DAT), flazalone only achieved 5700nM for the same receptor (even weaker than for the phenindamine precursor which was 4420nM). However, the para-methyl compound was the one titled in the article publications. This had a Ki of 492nM for the mazindol binding site (DAT), which is more promising than flazalone if we are only talking about this receptor. For comparison consider WIN 35,428 versus RTI-32.
Synthesis
The synthesis has been covered: Patents: Alternate synthesis: 62%: N.B. The p-fluoroacetophenone [403-42-9] has dual use in the synthesis of Enecadin [259525-01-4].
See also
Phenindamine
Text derived from https://en.wikipedia.org/w/index.php?oldid=1330818203 under CC BY-SA 4.0; modifications have been made.